During the past decade, Sahyadri Clinical Research and Development Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahyadri Clinical Research and Development Center" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sahyadri Clinical Research and Development Center" are "Hemophilia A" (2 trials), "Hemophilia B" (2 trials), "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Sahyadri Clinical Research and Development Center" in a lesser frequency.

Most popular intervention types in "Sahyadri Clinical Research and Development Center" are "Drug" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lorlatinib" (2 trials), "placebo" (2 trials), "pregabalin" (2 trials), "Any approved or standard-of-care therapy" (1 trials) and "Crizotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sahyadri Clinical Research and Development Center" are 8 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sahyadri Clinical Research and Development Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sahyadri Clinical Research and Development Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sahyadri Clinical Research and Development Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".